Efficacy of Tyrosine Kinase Inhibitor Therapy in a Chemotherapy-refractory B-cell Precursor Acute Lymphoblastic Leukemia With ZC3HAV1-ABL2 Fusion. Issue 3 (June 2019) - Decool, Gauthier; Domenech, Carine; Grardel, Nathalie; Plesa, Adriana; Raczkiewicz, Imelda; Ducourneau, Benoit; Ruminy, Philippe; Pages, Marie-Pierre; Girard, Sandrine; Fenwarth, Laurène; Preudhomme, Claude; Bertrand, Yves; et al.